203 related articles for article (PubMed ID: 29703818)
1. Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy.
Hertz DL; Kidwell KM; Vangipuram K; Li F; Pai MP; Burness M; Griggs JJ; Schott AF; Van Poznak C; Hayes DF; Lavoie Smith EM; Henry NL
Clin Cancer Res; 2018 Aug; 24(15):3602-3610. PubMed ID: 29703818
[No Abstract] [Full Text] [Related]
2. Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy.
Sun Y; Kim JH; Vangipuram K; Hayes DF; Smith EML; Yeomans L; Henry NL; Stringer KA; Hertz DL
Breast Cancer Res Treat; 2018 Oct; 171(3):657-666. PubMed ID: 29946863
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy.
Jennaro TS; Fang F; Kidwell KM; Smith EML; Vangipuram K; Burness ML; Griggs JJ; Van Poznak C; Hayes DF; Henry NL; Hertz DL
Breast Cancer Res Treat; 2020 Apr; 180(3):707-714. PubMed ID: 32166478
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
Khalefa HG; Shawki MA; Aboelhassan R; El Wakeel LM
Breast Cancer Res Treat; 2020 Aug; 183(1):117-125. PubMed ID: 32601973
[TBL] [Abstract][Full Text] [Related]
5. Targeted Sequencing Reveals Low-Frequency Variants in
Apellániz-Ruiz M; Tejero H; Inglada-Pérez L; Sánchez-Barroso L; Gutiérrez-Gutiérrez G; Calvo I; Castelo B; Redondo A; García-Donás J; Romero-Laorden N; Sereno M; Merino M; Currás-Freixes M; Montero-Conde C; Mancikova V; Åvall-Lundqvist E; Green H; Al-Shahrour F; Cascón A; Robledo M; Rodríguez-Antona C
Clin Cancer Res; 2017 Mar; 23(5):1227-1235. PubMed ID: 27582484
[No Abstract] [Full Text] [Related]
6. Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy.
Kramer R; Bielawski J; Kistner-Griffin E; Othman A; Alecu I; Ernst D; Kornhauser D; Hornemann T; Spassieva S
FASEB J; 2015 Nov; 29(11):4461-72. PubMed ID: 26198449
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy.
Marcath LA; Kidwell KM; Vangipuram K; Gersch CL; Rae JM; Burness ML; Griggs JJ; Van Poznak C; Hayes DF; Smith EML; Henry NL; Beutler AS; Hertz DL
Br J Clin Pharmacol; 2020 May; 86(5):880-890. PubMed ID: 31823378
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
Baldwin RM; Owzar K; Zembutsu H; Chhibber A; Kubo M; Jiang C; Watson D; Eclov RJ; Mefford J; McLeod HL; Friedman PN; Hudis CA; Winer EP; Jorgenson EM; Witte JS; Shulman LN; Nakamura Y; Ratain MJ; Kroetz DL
Clin Cancer Res; 2012 Sep; 18(18):5099-109. PubMed ID: 22843789
[TBL] [Abstract][Full Text] [Related]
9. Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy.
Sánchez-Barroso L; Apellaniz-Ruiz M; Gutiérrez-Gutiérrez G; Santos M; Roldán-Romero JM; Curras M; Remacha L; Calsina B; Calvo I; Sereno M; Merino M; García-Donas J; Castelo B; Guerra E; Letón R; Montero-Conde C; Cascón A; Inglada-Pérez L; Robledo M; Rodríguez-Antona C
Oncologist; 2019 Aug; 24(8):e784-e792. PubMed ID: 30470691
[TBL] [Abstract][Full Text] [Related]
10. Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer.
Mielke S; Sparreboom A; Steinberg SM; Gelderblom H; Unger C; Behringer D; Mross K
Clin Cancer Res; 2005 Jul; 11(13):4843-50. PubMed ID: 16000582
[TBL] [Abstract][Full Text] [Related]
11. Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot study.
Salgado TM; Liu J; Reed HL; Quinn CS; Syverson JG; Le-Rademacher J; Lopez CL; Beutler AS; Loprinzi CL; Vangipuram K; Smith EML; Henry NL; Farris KB; Hertz DL
Breast; 2020 Jun; 51():21-28. PubMed ID: 32193049
[TBL] [Abstract][Full Text] [Related]
12. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
[TBL] [Abstract][Full Text] [Related]
13. Time-to-Event Analysis of Paclitaxel-Associated Peripheral Neuropathy in Advanced Non-Small-Cell Lung Cancer Highlighting Key Influential Treatment/Patient Factors.
Ojara FW; Henrich A; Frances N; Huisinga W; Hartung N; Joerger M; Kloft C
J Pharmacol Exp Ther; 2020 Dec; 375(3):430-438. PubMed ID: 33008871
[TBL] [Abstract][Full Text] [Related]
14. Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine.
Openshaw H; Beamon K; Synold TW; Longmate J; Slatkin NE; Doroshow JH; Forman S; Margolin K; Morgan R; Shibata S; Somlo G
Clin Cancer Res; 2004 Jan; 10(2):461-7. PubMed ID: 14760066
[TBL] [Abstract][Full Text] [Related]
15. Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer.
Speck RM; Sammel MD; Farrar JT; Hennessy S; Mao JJ; Stineman MG; DeMichele A
J Oncol Pract; 2013 Sep; 9(5):e234-40. PubMed ID: 23943894
[TBL] [Abstract][Full Text] [Related]
16. Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel.
Chen CS; Smith EML; Stringer KA; Henry NL; Hertz DL
Breast Cancer Res Treat; 2022 Aug; 194(3):551-560. PubMed ID: 35760975
[TBL] [Abstract][Full Text] [Related]
17. Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing.
Hertz DL; Chen L; Henry NL; Griggs JJ; Hayes DF; Derstine BA; Su GL; Wang SC; Pai MP
Br J Clin Pharmacol; 2022 Jul; 88(7):3222-3229. PubMed ID: 35083783
[TBL] [Abstract][Full Text] [Related]
18. Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial.
Hanai A; Ishiguro H; Sozu T; Tsuda M; Yano I; Nakagawa T; Imai S; Hamabe Y; Toi M; Arai H; Tsuboyama T
J Natl Cancer Inst; 2018 Feb; 110(2):141-148. PubMed ID: 29924336
[TBL] [Abstract][Full Text] [Related]
19. Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients.
Shigematsu H; Hirata T; Nishina M; Yasui D; Ozaki S
Support Care Cancer; 2020 Oct; 28(10):5005-5011. PubMed ID: 32036471
[TBL] [Abstract][Full Text] [Related]
20. Reversible peripheral neuropathy induced by a single administration of high-dose paclitaxel.
Iñiguez C; Larrodé P; Mayordomo JI; González P; Adelantado S; Yubero A; Trés A; Morales F
Neurology; 1998 Sep; 51(3):868-70. PubMed ID: 9748043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
